Concepedia

Publication | Open Access

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

DOIFull Paper Access

453

Citations

12

References

2020

Year

Toni K. Choueiri, Robert J. Motzer, Brian I. Rini, John B.A.G. Haanen, Matthew T. Campbell, B. Venugopal, Christian Kollmannsberger, Gwénaëlle Gravis, Mamoru Uemura, J.L. Lee,
Annals of Oncology

Abstract

NCT02684006.

References

YearCitations

Page 1